Backs the full staged build without dilution — the $514B contracted backlog justifies the record capex, the balance sheet ($242.5B cash vs. $112.8B debt, net debt just $42.3B) is a fortress, and the Sep 23 undercut-and-reclaim of the 200 SMA is a textbook shakeout, not a failure.
Argues waiting for high-volume confirmation above $342 means paying up at $350; wants the full initial tranche deployed now, with the $325.60 stop as the risk control.
Agrees the plan's structure is sound but not fully confirmed: the Sep 23 bounce came on falling volume, RSI at 50 gives no edge, and normalized earnings are closer to 32x, not the headline 16x.
Proposes cutting the initial tranche to ~30–40% of a standard allocation (vs. the trader's ~60–65%), keeping the $325.60 stop but sizing so a stop-out costs only ~0.25–0.5% of NAV, capping the total build at 100% (not 125%), and adding a tactical half-exit trigger on any close below $334 on above-average volume.
Rejects the trade as written — not Alphabet itself, but an unconfirmed technical pivot into a hostile rates tape (30-year Treasury at 2004 highs) sized as a leveraged bet: negative FCF, doubled debt, a new preferred line, and zero buybacks are a transformation-phase balance sheet, not a fortress.
Wants the initial tranche cut to a token 15–20% of a standard allocation, no add until a high-volume close above $342–343 or a genuine 328–332 undercut-and-reclaim of $334, the total capped at 100%, and any close below $334 on above-average volume triggering a full exit rather than waiting for the $325.60 disaster stop.
Thesis: The accelerating fundamentals outweigh the cash-flow-quality objections, but the unconfirmed technical pivot argues for a gradual build rather than a full-throttle Buy. Q2 2026 revenue of $119.8B (+24.2% YoY, capping a multi-year acceleration of 8.7%→13.9%→15.1%→24%), operating income of $40.77B with margins expanding to ~34%, a $514B cloud backlog up 82% YoY, and Gemini Enterprise in ~90% of the Fortune 100 are the strongest, most objective evidence in the debate. The balance sheet removes solvency risk ($242.5B cash and short-term investments vs. $112.8B total debt; net debt $42.3B). The bear's negative Q2 FCF (−$5.9B), doubled capex (~37% of revenue), zero buybacks, and new $18B preferred line are real but describe the funding cost of a demand-validated investment cycle — the bear never demonstrated that earnings estimates are being revised down. Two caveats temper conviction to Overweight rather than Buy: normalized net income annualizes to roughly $10.50/share (closer to ~32x, not the headline 16x, unless a forward consensus basis is confirmed), and the technical pivot is unconfirmed — the Sep 23 break of the 200 SMA printed 23.3M shares vs. only 15.9M/13.8M on the bounce, price sits just below the falling 50 SMA, RSI is exactly 50, and MACD is below zero, while a hawkish-Fed macro tape pressures long-duration multiples.
Action: start with a modest tranche (~30–50% of a standard allocation) near $338–341, sized so a stop-out at $325.60 costs no more than 0.5–1% of NAV; hold the remainder for either a $328–332 pullback that reclaims $334 or a volume-confirmed weekly close above $342 (never chase above $350), capping the total build near 100% of a standard allocation until Q3 earnings confirm. Treat a daily close below $334 on heavy volume as a de-risk trigger (cut at least half) and a weekly close below $325.60 as a full exit. Q3 earnings in late October are the key catalyst; what strengthens the call is a volume reclaim of $342 plus Q3 evidence that the backlog is converting into cash flow; what weakens it is negative FCF and zero buybacks persisting a second consecutive quarter, further yield spikes, or visible Microsoft Copilot-driven erosion of Google Cloud share.